Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Sun Pharmaceutical Industries Inc recalls Lisdexamfetamine Dimesylate Capsules

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 9 month long term stability station (25¿C, 60%RH).
Products
  • Lisdexamfetamine Dimesylate Capsules
Where it was sold

Recalled units were distributed to 17 distributors who may have further distributed the product nationwide.

Nationwide

Units affected
5,448 bottles
About this recall
Lisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottles, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceuticals, Inc., Cranbury, NJ 08512, NDC 57664-051-88